George A Scangos Vir Biotechnology, Inc. (VIR) insider trading activity

VIR Quotes by TradingView

George A Scangos is Director of Vir Biotechnology, Inc.. Currently has a direct ownership of 698,239 shares of VIR, which is worth approximately $3.66 Million. The most recent transaction as insider was on Feb 24, 2025, when has been sold 10,056 shares (Common Stock) at a price of $9.45 per share, resulting in proceeds of $95,029. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 698K
0% 3M change
477.11% 12M change
Total Value Held $3.66 Million

GEORGE A SCANGOS Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 24 2025
SELL
Open market or private sale
$95,029 $9.45 p/Share
10,056 Reduced 1.42%
698,239 Common Stock
Feb 18 2025
SELL
Open market or private sale
$107,556 $9.81 p/Share
10,964 Reduced 1.52%
708,295 Common Stock
Oct 23 2024
BUY
Other acquisition or disposition
-
598,270 Added 45.41%
719,259 Common Stock
May 30 2024
BUY
Grant, award, or other acquisition
-
8,000 Added 6.2%
120,989 Common Stock
Feb 26 2024
SELL
Open market or private sale
$206,461 $11.65 p/Share
17,722 Reduced 13.56%
112,989 Common Stock
Feb 22 2024
SELL
Open market or private sale
$100,781 $10.05 p/Share
10,028 Reduced 7.13%
130,711 Common Stock
Feb 20 2024
SELL
Open market or private sale
$172,431 $10.22 p/Share
16,872 Reduced 10.7%
140,739 Common Stock
Feb 16 2024
SELL
Open market or private sale
$111,390 $10.24 p/Share
10,878 Reduced 6.46%
157,611 Common Stock
Oct 17 2023
SELL
Other acquisition or disposition
-
1,750,000 Reduced 91.22%
168,489 Common Stock
Sep 15 2023
BUY
Other acquisition or disposition
-
1,750,000 Added 47.7%
1,918,489 Common Stock
Feb 24 2023
SELL
Open market or private sale
$350,004 $23.15 p/Share
15,119 Reduced 8.23%
168,489 Common Stock
Feb 23 2023
SELL
Open market or private sale
$328,027 $25.97 p/Share
12,631 Reduced 6.44%
183,608 Common Stock
Feb 21 2023
SELL
Open market or private sale
$507,288 $28.41 p/Share
17,856 Reduced 8.34%
196,239 Common Stock
Feb 17 2023
SELL
Open market or private sale
$250,219 $25.29 p/Share
9,894 Reduced 4.42%
214,095 Common Stock
Mar 10 2022
BUY
Grant, award, or other acquisition
-
111,000 Added 33.14%
223,989 Common Stock
Feb 18 2022
SELL
Open market or private sale
$543,302 $30.65 p/Share
17,726 Reduced 13.56%
112,989 Common Stock
Feb 17 2022
SELL
Open market or private sale
$320,066 $31.93 p/Share
10,024 Reduced 7.12%
130,715 Common Stock
Feb 16 2021
BUY
Grant, award, or other acquisition
-
111,000 Added 2.35%
4,609,559 Common Stock

Also insider at

A
AGILENT TECHNOLOGIES, INC. Healthcare
Director
VYGR
Voyager Therapeutics, Inc. Healthcare
Director
GAS

George A Scangos

Director
Santa Clara, CA

Track Institutional and Insider Activities on VIR

Follow Vir Biotechnology, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VIR shares.

Notify only if

Insider Trading

Get notified when an Vir Biotechnology, Inc. insider buys or sells VIR shares.

Notify only if

News

Receive news related to Vir Biotechnology, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on VIR